In this study, we evaluated the prevalence of these variants and genes in our NPC discovery cohort, replicating the association between NPC and six variants in BRD2 and GABBR1, and four genes (BRD2, CTNNB1, TRMT10B, and IRF5). This evidence concerns the gene BRD2 and nasopharyngeal carcinoma.